BioNTech SE - ADR vs Endeavour Silver Corp — how do they compare? BioNTech SE - ADR trades at $92.23 (market cap $23.31B), while Endeavour Silver Corp trades at $10.84 (market cap $3.14B). The key difference: BioNTech SE - ADR is far larger — about 7.4× Endeavour Silver Corp's market cap, and Endeavour Silver Corp is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | EXK | |
|---|---|---|
Market Cap | $23.31B | $3.14B |
Sector | Health | Basic Materials |
52-Week High | $119.34 | $14.12 |
52-Week Low | $83.89 | $5.31 |
Enterprise Value | $6.60B | $3.14B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
EXK is trading at $9.54, up 8.04% today, with strong technical momentum and bullish moving average signals. The company shows improving fundamentals with Q2 2026 earnings matching estimates and revenue growth from $468M in 2025 to $737M projected for 2026. Recent news highlights a $25M credit facility and operational expansion at Terronera mine.
Outlook remains positive with analyst consensus price target of $15.50 (62% upside), though risks include volatile earnings history and elevated P/E ratio of 51.2. The stock offers growth potential through silver production expansion but faces commodity price sensitivity and execution risks in mine development.
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Endeavour Silver is a mid-tier precious metals mining company. It operates silver-gold mines in Mexico and is focused on growing its production and reserves through exploration and the development of new mining projects.
Read more on EXK →